ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V
Product details
Registration number: SIN15263P
Classification: Prescription Only
Active ingredients: Ropivacaine base 1.765 mg/mL eqv Ropivacaine hydrochloride
Strength: 2.0 mg/mL
Dosage form: INJECTION, SOLUTION
Route: EPIDURAL
Registrant: APEX PHARMA MARKETING PTE. LTD.
ATC code: N01BB09
HSA approval date: 8 June 2017
Manufacturer(s): Elpen Pharmaceutical Co., Inc
Manufacturing country/countries: GREECE
What are the HSA registration number and classification for ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15263P
Classification: Prescription Only
What active ingredients and strength are recorded for ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ropivacaine base 1.765 mg/mL eqv Ropivacaine hydrochloride
Strength: 2.0 mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: EPIDURAL
Who is the recorded registrant for ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V?
According to the HSA dataset updated 7 August 2026:
Registrant: APEX PHARMA MARKETING PTE. LTD.
Which manufacturers and countries are listed for ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Elpen Pharmaceutical Co., Inc
Manufacturing country/countries: GREECE
Where can I look up ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15263P or the exact product name ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V. The general register link does not preselect this product.
What are the source dates for this ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ROPIVACAINE-AFT SOLUTION FOR INJECTION 0.2% W/V record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15263P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)